452 companies

4D Molecular Therapeutics

Market Cap: US$190.3m

A clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platform in the Netherland and the United States.

FDMT

US$4.18

7D

7.3%

1Y

-86.5%

Silence Therapeutics

Market Cap: US$184.6m

A biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

SLN

US$3.90

7D

-13.3%

1Y

-83.8%

Dermata Therapeutics

Market Cap: US$4.7m

A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases.

DRMA

US$1.17

7D

-7.1%

1Y

-79.4%

Context Therapeutics

Market Cap: US$63.3m

A biopharmaceutical company, develops products for the treatment of solid tumors.

CNTX

US$0.84

7D

10.1%

1Y

-22.1%

Captor Capital

Market Cap: CA$3.1m

Engages in the retail sale of cannabis products in the United States.

CPTR

CA$0.89

7D

25.4%

1Y

-15.2%

Microbix Biosystems

Market Cap: CA$54.0m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

MBX

CA$0.39

7D

2.7%

1Y

2.7%

Adverum Biotechnologies

Market Cap: US$95.9m

A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.

ADVM

US$4.73

7D

7.5%

1Y

-73.3%

Marker Therapeutics

Market Cap: US$13.2m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

MRKR

US$1.28

7D

-16.3%

1Y

-70.4%

BioRestorative Therapies

Market Cap: US$12.2m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

BRTX

US$1.67

7D

8.4%

1Y

20.1%

Nykode Therapeutics

Market Cap: NOK 740.6m

A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies.

NYKD

NOK 2.27

7D

12.3%

1Y

-84.0%

Poolbeg Pharma

Market Cap: UK£14.3m

Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.

POLB

UK£0.029

7D

-1.7%

1Y

-71.2%

Nanologica

Market Cap: SEK 148.9m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.

NICA

SEK 1.69

7D

1.8%

1Y

-74.1%

AC Immune

Market Cap: US$226.6m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

ACIU

US$2.21

7D

-7.7%

1Y

-36.9%

Gossamer Bio

Market Cap: US$328.6m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

GOSS

US$1.39

7D

20.9%

1Y

0.7%

Nuvation Bio

Market Cap: US$724.8m

A clinical-stage biopharmaceutical company, focuses on unmet needs in oncology by developing differentiated and novel therapeutic candidates.

NUVB

US$2.09

7D

11.2%

1Y

-7.5%

ProPhase Labs

Market Cap: US$11.9m

Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.

PRPH

US$0.39

7D

3.6%

1Y

-92.3%

Skye Bioscience

Market Cap: US$75.8m

A biopharmaceutical company, focuses on unlocking new therapeutic pathways for metabolic health through the development of molecules that modulate G-protein coupled receptors.

SKYE

US$2.53

7D

-0.4%

1Y

-81.3%

AroCell

Market Cap: SEK 117.5m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

AROC

SEK 0.51

7D

1.0%

1Y

43.7%

Opus Genetics

Market Cap: US$29.5m

A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders.

IRD

US$0.94

7D

1.3%

1Y

-51.2%

BioCardia

Market Cap: US$11.9m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

BCDA

US$2.62

7D

3.1%

1Y

-54.8%

Sera Prognostics

Market Cap: US$142.4m

A women’s health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States.

SERA

US$4.14

7D

0%

1Y

-53.8%

Moleculin Biotech

Market Cap: US$3.4m

A clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses.

MBRX

US$1.13

7D

-1.7%

1Y

-86.3%

Ovoca Bio

Market Cap: €856.4k

A clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health.

OVXA

€0.011

7D

0%

1Y

110.0%

Valbiotis

Market Cap: €17.5m

Engages in the research and development of health nutrition products to prevent and control metabolic and cardiovascular diseases in France.

ALVAL

€1.11

7D

3.2%

1Y

-71.1%

Sensei Biotherapeutics

Market Cap: US$11.3m

An immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients.

SNSE

US$0.44

7D

3.8%

1Y

-58.1%

Werewolf Therapeutics

Market Cap: US$53.8m

A biopharmaceutical company, develops therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.

HOWL

US$1.17

7D

-4.5%

1Y

-80.6%

Biomea Fusion

Market Cap: US$92.0m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.

BMEA

US$2.52

7D

0.6%

1Y

-84.0%

Prime Medicine

Market Cap: US$228.5m

A biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology.

PRME

US$1.75

7D

-15.9%

1Y

-75.1%

Acelyrin

Market Cap: US$276.9m

A clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.

SLRN

US$2.75

7D

5.6%

1Y

-63.9%

AIM Vaccine

Market Cap: HK$4.7b

Researches, develops, manufactures, and commercializes of vaccine products for human use in the People’s Republic of China.

6660

HK$3.91

7D

-4.6%

1Y

-54.1%

PYC Therapeutics

Market Cap: AU$545.9m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

PYC

AU$1.17

7D

-6.4%

1Y

46.3%

Intervacc

Market Cap: SEK 325.5m

Develops novel veterinary vaccines for animals in Sweden.

IVACC

SEK 0.95

7D

-6.4%

1Y

-73.2%

TNF Pharmaceuticals

Market Cap: US$1.0m

A clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.

TNFA

US$0.39

7D

9.0%

1Y

-86.3%

Stem Cells Spin

Market Cap: zł7.8m

Operates as a biotechnology company in Poland.

SCS

zł0.19

7D

-2.6%

1Y

-67.4%

Aprea Therapeutics

Market Cap: US$13.0m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

APRE

US$2.34

7D

4.9%

1Y

-64.3%

Pliant Therapeutics

Market Cap: US$94.3m

A clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States.

PLRX

US$1.70

7D

18.9%

1Y

-88.4%

Page 4 of 13